319 related articles for article (PubMed ID: 23886798)
1. Clinical outcomes of single dose stereotactic radiotherapy for lung metastases.
Osti MF; Carnevale A; Valeriani M; De Sanctis V; Minniti G; Cortesi E; Martelli M; Maurizi Enrici R
Clin Lung Cancer; 2013 Nov; 14(6):699-703. PubMed ID: 23886798
[TBL] [Abstract][Full Text] [Related]
2. Repeat stereotactic body radiation therapy for patients with pulmonary malignancies who had previously received SBRT to the same or an adjacent tumor site.
Valakh V; Miyamoto C; Micaily B; Chan P; Neicu T; Li S
J Cancer Res Ther; 2013; 9(4):680-5. PubMed ID: 24518717
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Body Radiation Therapy (SBRT) for lung metastases.
Okunieff P; Petersen AL; Philip A; Milano MT; Katz AW; Boros L; Schell MC
Acta Oncol; 2006; 45(7):808-17. PubMed ID: 16982544
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases.
Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U
Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496
[TBL] [Abstract][Full Text] [Related]
6. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
Rusthoven KE; Kavanagh BD; Burri SH; Chen C; Cardenes H; Chidel MA; Pugh TJ; Kane M; Gaspar LE; Schefter TE
J Clin Oncol; 2009 Apr; 27(10):1579-84. PubMed ID: 19255320
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiotherapy for oligometastatic lung tumors.
Norihisa Y; Nagata Y; Takayama K; Matsuo Y; Sakamoto T; Sakamoto M; Mizowaki T; Yano S; Hiraoka M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):398-403. PubMed ID: 18374506
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions.
Inoue T; Katoh N; Aoyama H; Onimaru R; Taguchi H; Onodera S; Yamaguchi S; Shirato H
Jpn J Clin Oncol; 2010 Aug; 40(8):788-94. PubMed ID: 20406944
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic analysis of stereotactic radiotherapy for 39 patients with lung metastasis].
Wu SX; Deng ML; Bao Y; Wang HY; Gao YH; Li FY; Huang SM
Ai Zheng; 2006 Jul; 25(7):880-4. PubMed ID: 16831282
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study.
Nuyttens JJ; van der Voort van Zyp NC; Verhoef C; Maat A; van Klaveren RJ; van der Holt B; Aerts J; Hoogeman M
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):337-43. PubMed ID: 25636758
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients.
Wulf J; Haedinger U; Oppitz U; Thiele W; Mueller G; Flentje M
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):186-96. PubMed ID: 15337555
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single-institution results.
Carvajal C; Navarro-Martin A; Cacicedo J; Ramos R; Guedea F
J BUON; 2015; 20(1):158-65. PubMed ID: 25778311
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer.
Scorsetti M; Franceschini D; De Rose F; Comito T; Villa E; Iftode C; Navarria P; D'Agostino GR; Masci G; Torrisi R; Testori A; Tinterri C; Santoro A
Breast; 2016 Apr; 26():11-7. PubMed ID: 27017237
[TBL] [Abstract][Full Text] [Related]
14. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
[TBL] [Abstract][Full Text] [Related]
15. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries.
Baumann P; Nyman J; Lax I; Friesland S; Hoyer M; Rehn Ericsson S; Johansson KA; Ekberg L; Morhed E; Paludan M; Wittgren L; Blomgren H; Lewensohn R
Acta Oncol; 2006; 45(7):787-95. PubMed ID: 16982541
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiation therapy for lung metastases.
Ricardi U; Filippi AR; Guarneri A; Ragona R; Mantovani C; Giglioli F; Botticella A; Ciammella P; Iftode C; Buffoni L; Ruffini E; Scagliotti GV
Lung Cancer; 2012 Jan; 75(1):77-81. PubMed ID: 21726918
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.
Nagata Y; Takayama K; Matsuo Y; Norihisa Y; Mizowaki T; Sakamoto T; Sakamoto M; Mitsumori M; Shibuya K; Araki N; Yano S; Hiraoka M
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1427-31. PubMed ID: 16169670
[TBL] [Abstract][Full Text] [Related]
18. Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases.
Minniti G; Esposito V; Clarke E; Scaringi C; Lanzetta G; Salvati M; Raco A; Bozzao A; Maurizi Enrici R
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):623-9. PubMed ID: 23683828
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of biological effective dose-based fractionated stereotactic radiation therapy for metastatic brain tumors from non-small cell lung cancer.
Matsuyama T; Kogo K; Oya N
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):984-90. PubMed ID: 23092725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
